InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Lennon David James. Director active across 2 companies, notably Aadi Bioscience, Inc.. Cumulatively, 9 filings have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €897k. History available since 2 October 2024. The latest transaction was filed on 9 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Lennon David James is chief executive officer at Whitehawk Therapeutics, Inc. and Aadi Bioscience, Inc. He has 9 filings in total, and across the 9 sampled recent filings between 2024-10-03 and 2026-04-10, the modal transaction nature is Sale, with EUR 896927 in sales and EUR 0 in purchases.